€0.32 0.0 1.0%
Last Trade - 11:12am
| Market Cap | ÂŁ5.98m |
| Enterprise Value | ÂŁ8.16m |
| Revenue | ÂŁn/a |
| Position in Universe | 801st / 847 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.005 | 0.004 | 0.000 | 0.000 | 0.000 | 0.000 | -100.0% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Asit Biotech SA, formerly Biotech Tools SA, is a Belgium- based company that develops products aimed to prevent negative response of the immune system.
| Last Annual | December 31st, 2019 |
| Last Interim | June 30th, 2020 |
| Incorporated | June 5, 1997 |
| Public Since | May 11, 2016 |
| No. of Shareholders: | n/a |
| No. of Employees: | 20 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | Euronext - Brussels |
| Shares in Issue | 21,892,592 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 7 Rue des Chasseurs Ardennais,Liege (Angleur), LIEGE, 4031, Belgium |
| Web | https://www.asitbiotech.com/index.php |
| Phone | +32 2 2640390 |
| Contact | () |
| Auditors | Mazars Reviseurs d Entreprises SCRL |
As of 11:12am, shares in Asit Biotech SA are trading at €0.32, giving the company a market capitalisation of £5.98m. This share price information is delayed by 15 minutes.
Shares in Asit Biotech SA are currently trading at €0.32 and the price has moved by 53.88% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Asit Biotech SA price has moved by 38.94% over the past year.
Of the analysts with advisory recommendations for Asit Biotech SA, there are there are currently 0 "buy" , 0 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Asit Biotech SA is Strong Sell. You can view the full broker recommendation list by unlocking its StockReport.
Asit Biotech SA is scheduled to issue upcoming financial results on the following dates:
Asit Biotech SA does not currently pay a dividend.
Asit Biotech SA does not currently pay a dividend.
Asit Biotech SA does not currently pay a dividend.
To buy shares in Asit Biotech SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Asit Biotech SA are currently trading at €0.32, giving the company a market capitalisation of £5.98m.
Here are the trading details for Asit Biotech SA:
Based on an overall assessment of its quality, value and momentum, Asit Biotech SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Asit Biotech SA are currently priced at €0.32. At that level they are trading at 52.68% premium to the analyst consensus target price of 0.00.
Analysts covering Asit Biotech SA currently have a consensus Earnings Per Share (EPS) forecast of -0.8 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Asit Biotech SA. Over the past six months, the relative strength of its shares against the market has been 62.26%. At the current price of €0.32, shares in Asit Biotech SA are trading at 40.65% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Asit Biotech SA.
Asit Biotech SA's management team is headed by:
Here are the top five shareholders of Asit Biotech SA based on the size of their shareholding:
